The Infectious Diseases Society of America has agreed to a settlement, bringing to a close an investigation by the Connecticut Attorney General over possible antitrust violations. At issue is IDSA’s position against prolonged use of antibiotics to treat Lyme disease. In the settlement agreement, IDSA denied any wrongdoing, but agreed to review its clinical guidelines and name an ombudsman to evaluate its review panel for conflicts of interest.
To see more Daily News articles, click here.
To go to the Drug Topics homepage, click here.
